| Control group [10] Mean ± SD | Group 2 [10] olanzapine Mean ± SD | Group 3 [10] aripeprazole Mean ± SD | Group 4 [10] Olanzapine +aripeprazole Mean ± SD | F test | P value |
Baseline wt[gm] | 179.5 ± 14.81 | 182.5 ± 20.17 | 181.2 ± 13.29 | 177.9 ± 17.79 | 0.15 | 0.93 |
Wt at End of study [gm] | 247.2 ± 28.92 | 288.1 ± 51.05$ | 221.4 ± 20.9^ | 253.3 ± 36.62^ | 5.78 | 0.002** |
Liver wt[gm] | 12.095 ± 0.23 | 13.76 ± 0.45$ | 12.22 ± 0.15^ | 13.01 ± 0.38$^?/span> | 55.87 | <0.001** |
total Cholesterol | 54.8 ± 20.71 | 77.68 ± 21.5$ | 50.91 ± 22.15^ | 62.8 ± 4.59 | 4.0 | 0.015* |
FBS | 124.97 ± 5.25 | 141.4 ± 10.11$ | 126.0 ± 7.67^ | 129.7 ± 8.58^ | 8.66 | <0.001** |
Triglycerides | 130.0 ± 8.19 | 215.4 ± 13.43$ | 133.1 ± 11.17^ | 171.2 ± 16.92$^?/span> | 97.08 | <0.001** |
ALT | 24.32 ± 1.26 | 67.3 ± 1.63$ | 27.46 ± 1.72$^ | 58.23 ± 1.1$^?/span> | 2230.0 | <0.001** |
AST | 51.59 ± 1.42 | 89.64 ± 1.73$ | 54.64 ± 1.43$^ | 73.41 ± 1.57$^?/span> | 1319.8 | <0.001** |
AlP | 71.73 ± 1.24 | 79.07 ± 1.37$ | 74.22 ± 0.90$^ | 76.55 ± 1.47$^?/span> | 61.88 | <0.001** |
Bilirubin | 0.49 ± 0.03 | 0.81 ± 0.08$ | 0.57 ± 0.14^ | 0.64 ± 0.13$^ | 16.88 | <0.001** |